Herbst, R. S., Paz-Ares, L. G., Reck, M., Awad, M. M., Hayashi, H., Zhang, J., Schneider, A., Zhou, H., Parent, A. A., Okaniwa, M., Lu, S. (2026). Randomized phase 3 study (MarsLight-11) evaluating IBI363 (TAK-928) versus docetaxel in patients (pts) with squamous non-small cell lung cancer (sqNSCLC) after prior chemotherapy (chemo) and immunotherapy (IO).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8673